Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOBOCERTINIB vs MOMELOTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOBOCERTINIB vs MOMELOTINIB: Safety Overview

Metric MOBOCERTINIB MOMELOTINIB
Total FAERS Reports 715 909
Deaths Reported 320 143
Death Rate 44.8% 15.7%
Hospitalizations 227 213
Average Patient Age 65.7 yrs 73.2 yrs
% Female Patients 66.1% 49.4%
FDA Approval Date Sep 15, 2021 Sep 15, 2023
Manufacturer N/A GlaxoSmithKline LLC
Route N/A ORAL
Marketing Status Discontinued Prescription